We Help Companies Find New Sales Opportunities
Chemicals & Pharmaceuticals - 2014
Banner Chemicals has acquired Stowlin Croftshaw, the Leicester-based cleaning and industrial chemicals firm, for undisclosed terms.
Cell Therapy Catapult is to build a £55m cell therapy manufacturing centre at the Stevenage Bioscience campus, with the creation of 150 jobs.
Midatech is to relocate its medical laboratory from Kidlington to its Milton Park site near Abingdon next year, with the creation of up to ten jobs.
DE Pharmaceuticals is planning to expand its Tyneside-based wholesaling business with new distribution centres across the country, with the creation of 80 jobs.
Farrow & Ball, the Dorset-based paint manufacturer, has been acquired by US-based private equity fund Areas Management.
Cambrian Alliance has acquired CAMRx, the Leicestershire-based pharmacy buying group, for undisclosed terms.
PMC Pharmaceuticals is planning to expand its Cramlington-based wholesaling operation, with the creation of 25 jobs over the next two years.
AGC Chemicals Europe is to invest up to £8m in the development of a thermal treatment plant at its site in Lancashire.
Catalent has acquired Micron Technologies, the Kent-based particle-size engineering technology firm with 100 staff, for undisclosed terms.
Chester Medical Solutions is planning a £2m expansion at its Wirral-based pharmaceutical contract packing warehouse by next April, with the creation of 20 jobs.
Neal's Yard Remedies has won planning permission to expand its health products factory in Dorset, with the creation of 50 jobs.
Babraham Institute has won permission to expand its science innovation centre in Cambridge by 100,000 sq ft.
Christeyns UK is planning to expand its Bradford-based chemicals facility with an additional 50,000 sq ft of production and warehouse space.
SOG Group has acquired Sanofi's former 17-acre site in Dagenham, and will transform it into a life sciences business park called Londoneast-uk.
Pentagon Chemicals, the chemicals manufacturer with 180 staff in Widnes and Workington, has been acquired by Vertellus for undisclosed terms.
Solvents with Safety, the Doncaster-based supplier of solvents with 35 staff, has been acquired by Tradebe.
Reckitt Benckiser has unveiled details of its proposed 13,000 sq ft centre of excellence for consumer health products due to open in Hull by 2018.
Elekta Oncology has unveiled plans to open a new centre of excellence for 900 staff in Crawley in 2017.
Oxford BioMedica is planning to expand the workforce at its Oxford-based gene and cell therapy business from 120 to 150 by the middle of next year.
Redx Pharma has demerged its Redag Crop Protection agrochemicals business, which will create 20 research jobs at Alderley Park in Cheshire.
Parexel is to relocate its Nottingham-based pharmaceuticals research business to a 62,000 sq ft office at Castle Wharf.
Unilever has won permission to set up a £24m Advanced Manufacturing Centre in Port Sunlight by 2016.
Consort Medical is to acquire Aesica Holdco, the Northumberland-based contract pharmaceuticals manufacturer, for £230m.
Adaptimmune has secured funding of £64m to expand its Didcot-based pharmaceuticals research business, with the creation of 50 jobs.
Reinnervate, the County Durham-based cell culture research firm, has been acquired by Reprocell of Japan for £2.5m.
University of Liverpool is to proceed with plans to develop a £20m 60,000 sq ft Bio Innovation Hub on Crowne Street.
PZ Cussons has acquired a 6,000 sq ft office for its personal healthcare international project team at Airport City in Manchester.
Chiesi is to relocate its Manchester-based pharmaceuticals business to an 18,500 sq ft unit at the South Manchester business park.
GlaxoSmithKline has won permission from South Lakeland Council to build a pharmaceuticals plant in Ulverston by 2021, with the creation of 250 jobs.
Crest Medical is to relocate to a 100,000 sq ft warehouse at Chesford Grange in Warrington.
Biotec Services, the Bridgend-based provider of clinical trial services, has been acquired by US-based PCI for undisclosed terms.
Pharmacells is to create 12 new jobs at its Glasgow-based life sciences business, following its acquisition by Precious Cells.
University of Manchester has unveiled plans to develop a £60m Graphene Engineering Innovation Centre, in addition to the previously-announced National Graphene Institute.
Cytori Therapeutics of the US is relocating the European headquarters of its cell therapy business from Switzerland to Flintshire, with the creation of 30 jobs.
SPS Technologies has acquired KG Coating, the Wrexham-based aluminium and polymer coatings manufacturer, for £2.3m.
Nova Laboratories is to expand the spray drying facilities at its Leicester-based pharmaceuticals plant, with the creation of up to 20 jobs.
Hematogenix is to create up to 50 jobs at a new molecular services facility at Manchester Science Parks over the next three years.
Bristol Laboratories is to set up a pharmaceutical manufacturing plant at the former Reckitt Benckiser site in Peterlee, with the creation of 300 jobs.
Almac is to invest £54m in the expansion of its Craigavon-based pharmaceuticals manufacturing business, with the creation of 348 jobs.
SABIC is planning to upgrade its 223-acre Cracker chemical plant on Teesside to take shale gas by 2016, securing the future of hundreds of jobs.
Shire has acquired the trading assets of SCM Pharma, securing the future of 80 jobs at its Northumberland-based pharmaceutical manufacturing facilities.
Oxford University has won planning approval to build a disease research Big Data Institute for 600 staff in Headington, funded with £20m from the Li Ka Shing Foundation.
Peckforton, the Crewe-based pharmaceuticals manufacturer, has been acquired by Abbey Pharma in a deal supported by a £2m investment from Business Growth Fund.
Cat Tech Europe is seeking permission to expand its catalyst handling office and warehouse in Scunthorpe, with the creation of ten jobs.
Reckitt Benckiser is to invest £100m in a new household products research and development centre in Hull by 2018, securing 1,200 jobs.
MedPharm is to expand the laboratory and office space at its pharmaceuticals research facility in Guildford, with the creation of up to 15 jobs.
Ineos has secured £230m of government support to build an import terminal and ethane store at Grangemouth, securing the future of thousands of jobs.
Wildacre Cosmetics is to create up to ten finance, technical and warehouse jobs at its contract manufacturing facility in Bingley.
Shire, the Basingstoke-based pharmaceuticals company, is to be acquired by US-based AbbVie for £31bn.
Centre for Process Innovation has unveiled plans to open a £20m medical research centre at its site in Darlington by 2017, with the creation of 20 jobs.
ALH Systems, the Wiltshire-based adhesives manufacturer with 37 staff, has been acquired by Indutrade of Sweden.
ProStrakan has acquired Archimedes Pharma, the Reading-based pharmaceuticals supplier, for £230m.
Randox Laboratories is to recruit an additional 50 staff at its Antrim-based medical tests business by September.
Cipla of India is to invest up to £100m in the UK, in order to support the development of a range of respiratory, oncology and antiretroviral medicines.
D2N2 has announced funding of £6.5m to develop a new 50,000 sq ft building at the BioCity life sciences centre in Nottingham, with the creation of up to 200 jobs.
Concept Life Sciences is creating a new Manchester-based analytical testing group with 550 staff, following the acquisition of Peakdale Molecular, Resource & Environmental Consultants and Scientific Analysis Laboratories.
Barrier Group is planning to build a new £1.8m coatings factory and office in Wallsend by 2015, with the creation of 30 jobs.
Surepharm Services is investing £3.6m in a new packaging line at its pharmaceuticals factory in Burton.
Simbec Research is to merge with Orion Clinical Services to create an enlarged clinical research group with 250 staff.
Thornton & Ross of Huddersfield has acquired the Flexitol skin treatment brand from LaCorium Health for undisclosed terms.
Actavis is to invest £6m in the expansion of its Barnstaple-based pharmaceutical manufacturing business.
Premaitha Health, the Manchester-based molecular diagnostics firm, is to undergo a £10m reverse takeover by ViaLogy.
Almac is to create 20 jobs at its pharmaceutical services business in Craigavon.
Adaptimmune is to expand the 30-strong workforce at its Abingdon-based biotechnology business with 40 new jobs by the end of the year.
Exco InTouch is planning to expand the 40-strong workforce at its Nottingham-based clinical trials business with at least ten new jobs.
DCC Healthcare has acquired Williams Medical, the South Wales-based supplier of pharmaceuticals with 165 staff, for £45m.
Euprotec, the Manchester-based biotechnology firm, has been acquired by Evotec of Germany for undisclosed terms.
Nova Laboratories is to expand the 200-strong workforce at its Leicester-based pharmaceuticals plant with about 60 new jobs over the next five years.
Bee Health is creating up to 50 jobs at its factory in Bridlington, having installed new machinery to manufacture soft gel capsules.
Estee Lauder Cosmetics has confirmed plans to set up a 144,000 sq ft headquarters at 1 Fitzroy Place in London in 2015.
GlaxoSmithKline has won approval for the £100m expansion of its pharmaceuticals plant in Worthing by 2017.
GlaxoSmithKline is to submit plans for a £25m pharmaceutical ingredients manufacturing plant at its site in Montrose, with the creation of 25 jobs.
Hematogenix, the US diagnostics firm, is to set up a European headquarters at the BioHub in Alderley Park, with the creation of up to 15 jobs.
Christeyns UK has acquired Cole & Wilson, the Huddersfield-based dry cleaning chemicals manufacturer.
Randox has bought the assets of Trimega Laboratories out of administration, including a 6,500 sq ft forensic toxicology laboratory in Manchester.
The University of Dundee has secured a £8m Scottish Government investment to set up a new drug screening laboratory.
Perrigo UK is to invest £10m in improvements to the manufacturing and packaging equipment at its medicine plants in Braunton, Barnsley and Leeds over the next three years.
Cleveland Potash is to expand the Boulby Mine in North Yorkshire to produce Polyhalite, having won government approval for a £4.9m grant.
Mawdsleys has expanded its Salford-based pharmaceuticals distribution business with the acquisition of an additional 14,000 sq ft warehouse at Houston Park.
Lucideon is investing £1.5m in new pharmaceutical testing laboratories at its Stoke-based materials technology business.
GlaxoSmithKline is to sell its oncology products business to Novartis for £8.6bn, and will acquire Novartis' vaccines business for £4.2bn.
UK Inks, the St Helens-based printing ink manufacturer with 11 staff, has been sold out of administration by SFP.
Elekta is to expand its Crawley-based clinical solutions business with the £4.2m acquisition of an adjacent site at Manor Royal.
Amber Chemicals, the Somerset-based silicones manufacturer, has been acquired by US-based ICM Products.
University of Bath is to invest £53m in two new buildings with laboratories, research and studio space.
Retroscreen Virology is setting up a drug trials laboratory at Chesterford Research Park in Essex.
CSA Group is to set up a 27,000 sq ft Sira Certification testing facility at the Hawarden Business Park in Flintshire in 2015, with the creation of up to 50 jobs.
Manchester Science Parks has acquired the 400-acre Alderley Park life sciences research site in Cheshire from AstraZeneca, securing the future of about 700 jobs.
Interserve has won a £38m contract to build a pharmaceutical research laboratory at the Centre for Process Innovation in Darlington by March 2015.
Proteus Digital Health of the US is planning to set up a UK factory to manufacture ingestible pharmaceutical sensors, with the creation of 200 jobs.
Verona Pharma is to relocate its pharmaceuticals research business from London to Cardiff, having raised £14m in a share placing.
Retroscreen Virology has acquired Activiomics, the London-based proteomics company, for up to £4m.
Venn Life Sciences is to acquire the Wetherby-based skin research business of Evocutis for £0.2m.
Elucigene Diagnostics has bought the Manchester-based genetic testing kits division of Gen-Probe for undisclosed terms.
Impreglon UK has acquired Optical Coating Technologies, the Tamworth-based manufacturer of industrial coatings, for undisclosed terms.
Universal Products, the Lancashire-based beauty products manufacturer with 250 staff, has been acquired by DCC of Ireland for £13m.
Broadway Colours is to relocate its Suffolk-based polymer colours factory to a larger 90,000 sq ft site in Halesworth this summer.
UDG Healthcare is to sell its Northumberland-based Specials Laboratory, as well as Craig & Hayward and Arjun Products, to Professional Compounding Centers of America for £23m.
UPS has acquired Polar Speed, the Bedfordshire-based provider of pharmaceutical supply chain services with 118 vehicles.
James Briggs, the aerosol and chemicals manufacturer, is investing £1.5m in a new 10,000 sq ft commercial office and laboratory in Oldham.
Aromatherapy Associates, the London-based cosmetics supplier with 60 staff, has been acquired by B&B Investment Partners for an estimated £20m.
The Scottish Funding Council has awarded £10m to support the creation of the Industrial Biotechnology Innovation Centre at Strathclyde University in Glasgow, which could create up to 1,500 jobs.
Brenntag UK is to develop a new hydrochloric acid storage facility with a capacity of more than 2,000 tonnes at Seal Sands on Teesside.
Francis Dinsmore is investing £1m in the expansion of its Antrim-based textile coatings plant, with the creation of 16 jobs.
Grotech Production is to expand its Goole-based agrochemicals packing plant from 9,000 sq ft to 28,000 sq ft by July.
Itac has acquired Delvemade, creating a combined Manchester-based adhesives group with 36 staff.
Medvance, the Selby-based clinical research company, has been acquired by US-based NAMSA.
Estee Lauder, the cosmetics firm, is considering sites in London's Fitzroy Place and the Strand for a new 80,000 sq ft office.
Swansea University is to set up a £2.5m coatings research centre by 2015, with the creation of 40 jobs, as part of a government investment in 19 centres for doctoral training.
Sherwin-Williams, the US coatings supplier, is to set up a new 10,000 sq ft European headquarters at Manchester Airport's Voyager building, with the creation of 60 jobs.